SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $248 | +210.0% | 43,684 | +206.6% | 0.00% | +200.0% |
| Q4 2022 | $80 | -99.9% | 14,247 | -10.5% | 0.00% | 0.0% |
| Q3 2022 | $102,000 | +2.0% | 15,916 | +32.4% | 0.00% | 0.0% |
| Q4 2021 | $100,000 | -97.3% | 12,018 | -97.7% | 0.00% | -94.1% |
| Q3 2021 | $3,688,000 | +913.2% | 529,935 | +3372.7% | 0.02% | +750.0% |
| Q2 2021 | $364,000 | +4.9% | 15,260 | -9.5% | 0.00% | 0.0% |
| Q1 2021 | $347,000 | -25.1% | 16,859 | -10.7% | 0.00% | 0.0% |
| Q4 2020 | $463,000 | +245.5% | 18,885 | -33.0% | 0.00% | +100.0% |
| Q2 2020 | $134,000 | +294.1% | 28,188 | +167.9% | 0.00% | – |
| Q2 2019 | $34,000 | – | 10,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |